Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block

NCT ID: NCT01601925

Last Updated: 2013-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stellate ganglion block targets are C6 transverse process or C7 transverse process in anterior paratracheal approach which is most popular method. Cricoid cartilage is known that it is located at C6 level in supine neutral position of the neck. But stellate ganglion block is performed in supine extended position of the neck. So cricoid cartilage will move up to cephalad direction and pain doctors should find C6 or C7 transverse process at lower neck area than cricoid cartilage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Herpes Zoster CRPS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

neck extended group

We measured the distances from cricoid cartilage to C6 or C7 transverse process in supine neutral and extended position of the neck.

Group Type EXPERIMENTAL

supine extended position of the neck

Intervention Type OTHER

we measure the distances from cricoid cartilage to C6 or C7 transverse process in supine neutral and extended position of the neck

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

supine extended position of the neck

we measure the distances from cricoid cartilage to C6 or C7 transverse process in supine neutral and extended position of the neck

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adults above age of 20 reserved for musculoskeletal ultrasonography

Exclusion Criteria

1. past history of neck surgery
2. the limitation of neck motion due to rheumatoid arthritis, et al.
3. severe neck pain
4. inability to communicate or read or write
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

jong bum Choi

Yonsei University College of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jong B Choi

Role: STUDY_DIRECTOR

Yonsei University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gangnam Severance hospital

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jong B Choi

Role: CONTACT

82-2-2019-6093

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3-2011-0231

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.